ProfileGDS5678 / 1458370_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 96% 96% 96% 95% 96% 97% 97% 96% 96% 96% 96% 96% 96% 96% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 19.0368996
GSM967853U87-EV human glioblastoma xenograft - Control 29.0062596
GSM967854U87-EV human glioblastoma xenograft - Control 38.8047996
GSM967855U87-EV human glioblastoma xenograft - Control 48.7001595
GSM967856U87-EV human glioblastoma xenograft - Control 59.0113796
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 19.2293397
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 29.0915797
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 38.8982296
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 48.9673396
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 18.785296
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 28.9142396
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 38.8909896
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 49.0391696
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 58.9022696